Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndrome

Egyptian Liver Journal

Table 4 The final lipid profile parameters in the five study groups

	TGs (mg/dl)	TC (mg/dl)	LDL-C (mg/dl)	HDL-C (mg/dl)
C(9)	83.11 ±3.93	144.22 ±4.25	69.16 ±5.09	58.44±1.57
MS (10)	136.30±4.70^a	213.00±9.18^a	158.34±10.20^a	27.40±1.55^a
MSRD (9)	107.56±3.22^a,b	176.33±5.63 ^a,b	109.71±4.96 ^a,b	45.11±1.62 ^a,b
MSF(9)	103.22±3.67 ^a,b	165.67±7.56 ^a,b	96.80±8.65 ^a,b	48.22±2.60 ^a,b
MSRDF (9)	94.89±3.16 ^a,b,c	142.89±6.49^b,c,d	74.69±6.26 ^b,c,d	49.22±2.40^a,b

C, control group, MS, untreated metabolic syndrome group, MSRD, metabolic syndrome group reverted to regular rat chow, MSF, metabolic syndrome group on alternate day fasting, MSRDF, metabolic syndrome group reverted to regular rat chow and on alternate day fasting; TGs, triglycerides; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol
Data are expressed as mean ± SEM
In the parenthesis is the number of observations
a_: Significance from control group, by LSD test at P ≤0.05
b: Significance from MS group, by LSD test at P ≤0.05
c: Significance from MSRD group, by LSD test at P ≤0.05
d: Significance from MSF group, by LSD test at P ≤0.05